Isha Deshpande

  The global Biomimetic Technology Market is forecasted to be worth USD 17.73 Billion by 2027, according to a current analysis by Emergen Research.The Biomimetic Technology Market is anticipated to expand exponentially owing to the growing tissue engineering market. The Increasing elderly population would have a significant impact on market growth. The aging population is particularly vulnerable to cardiac, neurosurgery, and orthopedic problems. The rising usage of biomimetics in the cardiac sector will also boost the growth of the biomimetics technology market during the forecast timeline. Besides, the increasing organ failure cases among the geriatric population are expected to propel the demand for this technology shortly. Emergen Research has published a research report on global  Biomimetic Technology Market  to offer comprehensive analysis of current and emerging market trends along with key developments in the industry. The report offers in-depth information about ...

  The Global Anti-Drone or Counter-UAV Market is forecasted to be worth USD 4.60 billion by 2027, according to a current analysis by Emergen Research. The key factors influencing the market growth include growing adoption of the Anti-Drone by the defense agencies & intelligence bureau, growing adoption of the modern weaponry systems, increasing interest in the adoption of the DEW for the forthcoming combats, and rising interest upon the UAV, drones & missile destroyers, to name a few. Emergen Research has published a research report on global  Anti-Drone Market  to offer comprehensive analysis of current and emerging market trends along with key developments in the industry. The report offers in-depth information about market share, market size, market revenue growth, drivers, restraints, growth opportunities and challenges. The report also provides insights on different segments such as product types, applications, regional bifurcation along with top companies. T...

  The global PEEK market is projected to be worth USD 1,225.7 Million by 2027, according to a current analysis by Emergen Research. The PEEK (Polyether Ether Ketone) market is observing a high demand attributed to its increasing demand from the automotive industry. A growing emphasis on safety standards and eco-friendliness is a critical factor driving the demand for PEEK in the automotive industry, which consistently focuses on reducing manufacturing costs and improving efficiency and durability to provide prolonged warranties. The growing necessity for automotive weight reduction, fueled by the need to have better mileage and lower carbon dioxide emissions, are causative of the miniaturization of the automotive component and modules and functional incorporation. Consequently, OEMs are focusing on advanced and innovative materials such as PEEK, possessing lightweight and high specific strength to manufacture cost-effective parts with enhanced performance. Moreover, PEEK, with its ...

  The global synthetic biology market size reached USD 10.35 Billion in 2021 and is expected to register a revenue CAGR of 26.7% during the forecast period, according to latest analysis by Emergen Research. Rising research and development activities in this field of synthetic biology, growing application of synthetic biology including living biotherapeutics, multiplexed diagnostics, and third-generation biorefineries as well rising investments towards synthetic biology start-ups developing tools and services are some of the key factors driving the revenue growth of the synthetic biology market. The  Synthetic Biology Market  report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behaviour shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Synthetic Biology market. ...

  The global medical exoskeleton market size is expected to reach USD 6.25 Billion at a steady revenue CAGR of 45.0% in 2030, according to the latest analysis by Emergen Research. Large investments in the development of exoskeleton technology is driving revenue growth of the medical exoskeletons market. For instance, exoskeleton developer Wandercraft secured USD 45 million in Series C funding. Wandercraft is situated in Paris. The cash will be used by the business to develop and market a personal exoskeleton for use in the outdoors and at home, as well as hasten the introduction of Wandercraft's Atalante rehabilitation exoskeleton in the U.S. Atalante is a lower-body exoskeleton that can balance itself and mimics how individuals walk. In 2017, the business started the exoskeleton's clinical trials. In 2019, many drugs received Conformité Européene (CE) marking. With the use of the company's hands-free function, the exoskeleton is made to enable the wearer to move their uppe...

  The global Network as a Service (NaaS) market size reached USD 16.65 Billion in 2021 and is expected to register a revenue CAGR of 22.4 % during the forecast period, according to latest analysis by Emergen Research. Network as a Service (NaaS) is a critical component in enterprise network architecture for supporting the adaptation of innovative technologies depending on market demands, as well as for improving network performance, productivity, user experiences, and proactive maintenance. Owing to the increased internet penetration in functional business domains, many enterprises are deploying Network as a Service (Naas) in their business functions. Growing number of customers are turning to cloud alternatives to help them save money on network quality improvement. Network as a Service (NaaS) reduces costs by introducing new virtualized network infrastructure processes for hardware, software, operations, and maintenance. In addition, technological advancements in Machine Learning...

  During the forecast period, the size of the worldwide olfactory neuroblastoma market is anticipated to expand steadily in terms of revenue CAGR. The market is expanding as a result of a number of key factors, including the increased incidence of cancer and the number of clinical trials and research for the treatment of olfactory neuroblastoma. Additionally, the industry's revenue growth is being greatly aided by the recent rapid progress in clinical medication development for olfactory neuroblastoma. Olfactory neuroblastoma (ONB), often referred to as esthesioneuroblastoma, is a malignant neoplasm that appears in the olfactory epithelium in the ectopic sphenoclival area, the sphenoid sinus, or the upper portion of nasal canals. The  Olfactory Neuroblastoma Market  report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behaviour shifts, consumption and production patterns, product portfolio offered by the m...